Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K |
Revenues: |
Oral, Personal & Home Care | 14,110.0 | 13,588.0 | 13,168.0 | 13,156.0 | 13,162.0 | | 13,822.0 | 15,022.0 |
Pet Nutrition | 3,311.0 | 2,883.0 | 2,525.0 | 2,388.0 | 2,292.0 | | 2,212.0 | 2,255.0 |
Total revenues | 17,421.0 | 16,471.0 | 15,693.0 | 15,544.0 | 15,454.0 | 15,195.0 | 16,034.0 | 17,277.0 |
Revenue growth [+] | 5.8% | 5.0% | 1.0% | 0.6% | 1.7% | -5.2% | -7.2% | -0.8% |
Oral, Personal & Home Care | 3.8% | 3.2% | 0.1% | 0.0% | | | -8.0% | -1.2% |
Pet Nutrition | 14.8% | 14.2% | 5.7% | 4.2% | | | -1.9% | 2.0% |
Cost of goods sold | 7,046.0 | 6,454.0 | 6,368.0 | 6,313.0 | 6,174.0 | 6,072.0 | 6,635.0 | 7,168.0 |
Gross profit | 10,375.0 | 10,017.0 | 9,325.0 | 9,231.0 | 9,280.0 | 9,123.0 | 9,399.0 | 10,109.0 |
Gross margin | 59.6% | 60.8% | 59.4% | 59.4% | 60.0% | 60.0% | 58.6% | 58.5% |
Selling, general and administrative | 6,407.0 | 6,019.0 | 5,575.0 | 5,389.0 | 5,400.0 | 5,143.0 | 5,464.0 | 5,982.0 |
Other operating expenses | 636.0 | 126.0 | 139.0 | 60.0 | 21.0 | -68.0 | 976.0 | |
EBITDA [+] | 3,888.0 | 4,411.0 | 4,130.0 | 4,293.0 | 4,334.0 | 4,491.0 | 3,408.0 | 4,194.0 |
EBITDA growth | -11.9% | 6.8% | -3.8% | -0.9% | -3.5% | 31.8% | -18.7% | 5.0% |
EBITDA margin | 22.3% | 26.8% | 26.3% | 27.6% | 28.0% | 29.6% | 21.3% | 24.3% |
Depreciation | 467.0 | 451.0 | 457.0 | 452.0 | 440.0 | 410.0 | 416.0 | 410.0 |
EBITA | 3,421.0 | 3,960.0 | 3,673.0 | 3,841.0 | 3,894.0 | 4,081.0 | 2,992.0 | 3,784.0 |
EBITA margin | 19.6% | 24.0% | 23.4% | 24.7% | 25.2% | 26.9% | 18.7% | 21.9% |
Amortization of intangibles | 89.0 | 88.0 | 62.0 | 59.0 | 35.0 | 33.0 | 33.0 | 32.0 |
EBIT [+] | 3,332.0 | 3,872.0 | 3,611.0 | 3,782.0 | 3,859.0 | 4,048.0 | 2,959.0 | 3,752.0 |
EBIT growth | -13.9% | 7.2% | -4.5% | -2.0% | -4.7% | 36.8% | -21.1% | 5.5% |
EBIT margin | 19.1% | 23.5% | 23.0% | 24.3% | 25.0% | 26.6% | 18.5% | 21.7% |
Non-recurring items | | -13.0 | 57.0 | 88.0 | 152.0 | 93.0 | 170.0 | 195.0 |
Interest expense, net [+] | -192.0 | -183.0 | -192.0 | -193.0 | -153.0 | -149.0 | -133.0 | -82.0 |
Interest expense | -175.0 | -164.0 | -145.0 | -143.0 | -102.0 | -99.0 | -26.0 | 24.0 |
Interest income | 17.0 | 19.0 | 47.0 | 50.0 | 51.0 | 50.0 | 107.0 | 106.0 |
Other income (expense), net | -437.0 | -421.0 | -445.0 | -423.0 | -373.0 | -366.0 | -159.0 | -106.0 |
Pre-tax income | 3,087.0 | 3,647.0 | 3,301.0 | 3,464.0 | 3,487.0 | 3,738.0 | 2,763.0 | 3,533.0 |
Income taxes | 749.0 | 787.0 | 774.0 | 906.0 | 1,313.0 | 1,152.0 | 1,215.0 | 1,194.0 |
Tax rate | 24.3% | 21.6% | 23.4% | 26.2% | 37.7% | 30.8% | 44.0% | 33.8% |
Minority interest | 172.0 | 165.0 | 160.0 | 158.0 | 150.0 | 145.0 | 164.0 | 159.0 |
Net income | 2,166.0 | 2,695.0 | 2,367.0 | 2,400.0 | 2,024.0 | 2,441.0 | 1,384.0 | 2,180.0 |
Net margin | 12.4% | 16.4% | 15.1% | 15.4% | 13.1% | 16.1% | 8.6% | 12.6% |
|
Basic EPS [+] | $2.56 | $3.15 | $2.76 | $2.76 | $2.30 | $2.74 | $1.53 | $2.38 |
Growth | -18.5% | 14.2% | -0.1% | 20.1% | -16.1% | 78.4% | -35.6% | -1.1% |
Diluted EPS [+] | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 | $1.52 | $2.36 |
Growth | -18.6% | 14.1% | 0.0% | 20.6% | -16.1% | 78.6% | -35.5% | -1.1% |
|
Dividends per share [+] | $1.79 | $1.75 | $1.71 | $1.66 | $1.59 | $1.69 | $1.65 | $1.58 |
Growth | 2.3% | 2.3% | 3.0% | 4.4% | -6.0% | 2.2% | 4.7% | 6.4% |
|
Shares outstanding (basic) [+] | 845.0 | 856.8 | 859.1 | 870.6 | 881.8 | 891.8 | 902.2 | 915.1 |
Growth | -1.4% | -0.3% | -1.3% | -1.3% | -1.1% | -1.2% | -1.4% | -1.7% |
Shares outstanding (diluted) [+] | 848.3 | 859.3 | 861.1 | 873.0 | 887.8 | 898.4 | 909.7 | 924.3 |
Growth | -1.3% | -0.2% | -1.4% | -1.7% | -1.2% | -1.2% | -1.6% | -1.7% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|